Table 2.
Univariate Cox-regression | Multivariate Cox-regression | |||
---|---|---|---|---|
Parameter | P-value | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) |
suPAR (>5.956 ng/ml) | 0.001 | 2.304 (1.392–3.813) | 0.017 | 2.533 (1.185–5.418) |
Leukocyte count | 0.926 | 0.997 (0.930–1.068) | ||
CRP | 0.033 | 1.006 (1.000–1.011) | 0.180 | 1.005 (0.998–1.013) |
Platelets | 0.751 | 1.000 (0.997–1.002) | ||
AST | 0.178 | 1.002 (0.999–1.005) | 0.088 | 1.003 (0.999–1.007) |
Bilirubin | 0.098 | 1.051 (0.991–1.116) | 0.107 | 0.916 (0.823–1.019) |
ALP | 0.873 | 1.000 (0.999–1.001) | ||
LDH | 0.480 | 0.992 (0.972–1.013) | ||
Creatinine | 0.223 | 1.706 (0.772–4.031) | 0.557 | 1.325 (0.518–3.393) |
BMI | 0.927 | 0.998 (0.948–1.050) | ||
ECOG PS | 0.221 | 1.192 (0.899–1.581) | 0.251 | 0.797 (0.540–1.175) |
Age | 0.059 | 1.024 (0.999–1.050) | 0.198 | 1.022 (0.989–1.055) |
Sex | 0.663 | 0.889 (0.547–1.443) | ||
T-stage | 0.271 | 1.318 (0.807–2.153) |
ALP, alkaline phosphatase; AST, aspartate transaminase; BMI, body mass index; CRP, C-reactive protein; ECOG PS, ‘Eastern Cooperative Oncology Group’ performance status; LDH, lactate dehydrogenase.